Sexually Transmitted Disease Diagnostics Market Expected To Reach USD 6.4 Billion By 2032

Future Market Insights Global and Consulting Pvt. ltd.

The companies profiled in the Sexually Transmitted Disease Diagnostics market are Abbott Laboratories, Becton Dickinson Company, BioMérieux, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Diasorin Molecular LLC, Hologic, Inc., Orasure Technologies, Inc. , Roche Holding AG and Thermo Fisher Scientific Inc.

NEWARK, Del, May 23, 2022 (GLOBE NEWSWIRE) — The sexually transmitted disease diagnostics market is expected to grow at a CAGR of 7.9%, from USD 3.8 billion in 2022 to USD 6.4 billion through 2032.

The COVID-19 pandemic is an unprecedented global health threat, and its impact on testing for sexually transmitted diseases is expected to be disastrous. Due to disruptions in health care and testing services for sexually transmitted infections during the early months of the COVID-19 pandemic, the CDC reports, there have been fewer reports of sexually transmitted infections. In some cases, people spread infections unintentionally due to limited access to testing and diagnosis. Infection rates returned to normal as clinics reopened.

Among the types of diagnostic tests for sexually transmitted diseases, the market is divided into those for chlamydia, syphilis, gonorrhea, herpes simplex virus, human papillomavirus, and human immunodeficiency virus.

Request a sample report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14744

List of Key Players Covered in Sexually Transmitted Disease Diagnostics Market are:

  • Abbott Laboratories

  • Bio-Rad Laboratories

  • Qaigen Inc.

  • Diasorin SPA

  • MedMira Inc.

  • F.Hoffman

  • Hological

  • Cepheid

  • BioMeriuex

The growth of the sexually transmitted disease diagnostics market is expected to be driven by a number of factors including an increase in the prevalence of sexually transmitted diseases globally, patient awareness through education campaigns and government initiatives .

The prevalence and incidents of sexually transmitted diseases have increased dramatically over the past decade. In light of increasing prevalence, many countries are focusing on expanding the scope of diagnosis of sexually transmitted diseases by implementing national screening programs. The payment policies for these services are also favorable. Global screening for sexually transmitted diseases is growing due to these factors.

KEY POINTS TO REMEMBER:

  • The sexually transmitted disease diagnostics market is expected to expand at a CAGR of 7.2% through 2032 in the laboratory testing section of the diagnostic testing location category.

  • The CAGR for the laboratory devices segment of the device category in the sexually transmitted disease diagnostics market is expected to be 7.1% through 2032.

  • In the United States, the sexually transmitted disease diagnostics market is expected to reach $2.3 billion by 2032, growing at a CAGR of 7.7% throughout the forecast period.

  • By 2032, the UK sexually transmitted disease diagnostics market is expected to be valued at US$265.1 million growing at a CAGR of 6.7% till 2032.

  • With a CAGR of 7.2% throughout the forecast period, China is expected to reach a market size of US$ 442.0 million in the sexually transmitted disease diagnostics market by 2032.

  • By 2032, the sexually transmitted disease diagnostics market in Japan is estimated to be worth US$356.4 million, growing at an annual rate of 6.3% through 2032.

  • With a CAGR of 5.7% throughout the forecast period, South Korea is expected to reach a market size of US$ 222.4 million in the sexually transmitted disease diagnostics market by 2032.

Browse Detailed Abstract of Research Report with TOC: https://www.futuremarketinsights.com/reports/sexually-transmitted-diseases-diagnostics-market

COMPETITIVE LANDSCAPE:

The main companies presented in the sexually transmitted diseases diagnostics market report include Abbott Laboratories, Becton Dickinson Company, BioMérieux, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Diasorin Molecular LLC, Hologic, Inc., Orasure Technologies, Inc., Roche Holding AG, and Thermo Fisher Scientific Inc.

The demand for diagnosis of sexually transmitted diseases is largely in the North American market due to the availability of advanced FDA-approved testing devices and the widespread use of public health care plans, which facilitate awareness to health care.

Due to the prevalence of sexually transmitted infections in underdeveloped countries and the economic prosperity of Asia-Pacific, this region is expected to experience significant growth during the forecast period of 2021 to 2028.

Order a full research report: https://www.futuremarketinsights.com/checkout/14744

Detailed Table of Contents:

TOC Continued…!

Talk to our research expert: https://www.futuremarketinsights.com/ask-question/rep-gb-14744

See related research reports:

Multiplex Molecular Diagnostics Market Demands, Key Players, Emerging Technologies and Industry Potential to 2032

Specimen Retrieval Nets Market Analysis, Growth Status, Revenue Forecast to 2032

Recent Angiography Imaging Systems Market Trends, Development, Revenue, Demand and Forecast to 2032

About Future Market Insights (IMF)

Future Market Insights (ESOMAR certified market research organization and member of the Greater New York Chamber of Commerce) provides in-depth insights into the driving factors that increase demand in the market. It reveals opportunities that will drive market growth in various segments on the basis of source, application, sales channel, and end-use over the next 10 years.

Contact:

Future Market Outlook Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
Such. : +1-845-579-5705
For sales inquiries: [email protected]
Website: https://www.futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/sexually-transmitted-diseases-diagnostics-market
LinkedIn| Twitter| Blogs

Comments are closed.